| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Department of Pharmacology and Toxicology, University of Oulu, P. O. Box 5000, FIN-90014 University of Oulu, Finland [K. H. V., K. C.]; Division of Molecular Medicine, City of Hope/Beckman Research Institute, Fox Plaza South, Duarte, California 91010-3000 [W. P. B.]; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892 [J. A. W., M. A. K., B. B., C. C. H.]; and Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20892 [M. C. R. A.]
Somatic p53 mutations are common in lung cancer. Active cigarette smoking is positively correlated with the total frequency of p53 mutations and G:C to T:A transversions on the nontranscribed (DNA coding) strand. Mutational hotspots within the p53 gene, e.g., codon 157, have been identified for tobacco-related lung cancer, whereas these same mutations are found rarely in other cancers. Such data implicate specific p53 mutations as molecular markers of smoking. Because limited data exist concerning the p53 mutation frequency and spectra in ex-smokers and nonsmokers, we have analyzed p53 and K-ras mutations in 126 lung cancers from a population-based case-control study of nonsmoking (n = 117) or ex-smoking (n = 9) women from Missouri with quantitative assessments of exposure to environmental tobacco smoke. Mutations in the p53 gene were found in lung cancers from lifetime nonsmokers (19%) and ex-smokers (67%; odds ratio, 9.08; 95% confidence interval, 2.06–39.98). All deletions were found in tumors from patients who were either ex-smokers or nonsmokers exposed to passive smoking. The G:C to A:T transitions (11 of 28; 39%) were the most frequent p53 mutations found and clustered in tumors from lifetime nonsmokers without passive smoke exposure. The incidence of K-ras codon 12 or 13 mutations was 11% (14 of 115 analyzed) with no difference between long-term ex-smokers and nonsmokers. These and other results indicate that p53 mutations occur more commonly in smokers and ex-smokers than in never-smokers. Such comparisons provide additional evidence of genetic damage caused by tobacco smoke during lung carcinogenesis.
This article has been cited by other articles:
|
|
 |
|
  M. Seike, N. Yanaihara, E. D. Bowman, K. A. Zanetti, A. Budhu, K. Kumamoto, L. E. Mechanic, S. Matsumoto, J. Yokota, T. Shibata, et al. Use of a Cytokine Gene Expression Signature in Lung Adenocarcinoma and the Surrounding Tissue as a Prognostic Classifier J Natl Cancer Inst, August 15, 2007; 99(16): 1257 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Subramanian and R. Govindan Lung Cancer in Never Smokers: A Review J. Clin. Oncol., February 10, 2007; 25(5): 561 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Peltonen, J A Welsh, and K H Vahakangas Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene? Human and Experimental Toxicology, January 1, 2007; 26(1): 9 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Zhou, R. S. Heist, G. Liu, K. Asomaning, D. P. Miller, D. S. Neuberg, J. C. Wain, T. J. Lynch, and D. C. Christiani Second Hand Smoke Exposure and Survival in Early-Stage Non-Small-Cell Lung Cancer Patients Clin. Cancer Res., December 1, 2006; 12(23): 7187 - 7193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Y. S. Tam, L. P. Chung, W. S. Suen, E. Wang, M. C.M. Wong, K. K. Ho, W. K. Lam, S. W. Chiu, L. Girard, J. D. Minna, et al. Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non-Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features Clin. Cancer Res., March 1, 2006; 12(5): 1647 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tennis, S. Krishnan, M. Bonner, C. B. Ambrosone, J. E. Vena, K. Moysich, H. Swede, S. McCann, P. Hall, P. G. Shields, et al. p53 Mutation Analysis in Breast Tumors by a DNA Microarray Method Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 80 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Le Calvez, A. Mukeria, J. D. Hunt, O. Kelm, R. J. Hung, P. Taniere, P. Brennan, P. Boffetta, D. G. Zaridze, and P. Hainaut TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers Cancer Res., June 15, 2005; 65(12): 5076 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, K.-R. Muehlbauer, H. H. Schmeiser, M. Hergenhahn, D. Belharazem, and M. C. Hollstein p53 Mutations in Benzo(a)Pyrene-Exposed Human p53 Knock-in Murine Fibroblasts Correlate with p53 Mutations in Human Lung Tumors Cancer Res., April 1, 2005; 65(7): 2583 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shigematsu, L. Lin, T. Takahashi, M. Nomura, M. Suzuki, I. I. Wistuba, K. M. Fong, H. Lee, S. Toyooka, N. Shimizu, et al. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers J Natl Cancer Inst, March 2, 2005; 97(5): 339 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Mechanic, A. J. Marrogi, J. A. Welsh, E. D. Bowman, M. A. Khan, L. Enewold, Y.-L. Zheng, S. Chanock, P. G. Shields, and C. C. Harris Polymorphisms in XPD and TP53 and mutation in human lung cancer Carcinogenesis, March 1, 2005; 26(3): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Pulling, K. K. Divine, D. M. Klinge, F. D. Gilliland, T. Kang, A. G. Schwartz, T. J. Bocklage, and S. A. Belinsky Promoter Hypermethylation of the O6-Methylguanine-DNA Methyltransferase Gene: More Common in Lung Adenocarcinomas from Never-Smokers than Smokers and Associated with Tumor Progression Cancer Res., August 15, 2003; 63(16): 4842 - 4848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Santos Romeo, I. A. Sokolova, L. E. Morrison, C. Zeng, A. E. Baron, F. R. Hirsch, Y. E. Miller, W. A. Franklin, and M. Varella-Garcia Chromosomal Abnormalities in Non-Small Cell Lung Carcinomas and in Bronchial Epithelia of High-Risk Smokers Detected by Multi-Target Interphase Fluorescence in Situ Hybridization J. Mol. Diagn., May 1, 2003; 5(2): 103 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Brose, P. Volpe, M. Feldman, M. Kumar, I. Rishi, R. Gerrero, E. Einhorn, M. Herlyn, J. Minna, A. Nicholson, et al. BRAF and RAS Mutations in Human Lung Cancer and Melanoma Cancer Res., December 1, 2002; 62(23): 6997 - 7000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Husgafvel-Pursiainen Molecular biomarkers in studies on environmental cancer J Epidemiol Community Health, October 1, 2002; 56(10): 730 - 731. [Full Text] [PDF]
|
|
|
|
|
|
D. M. DeMarini, S. Landi, D. Tian, N. M. Hanley, X. Li, F. Hu, B. C. Roop, M. J. Mass, P. Keohavong, W. Gao, et al. Lung Tumor KRAS and TP53 Mutations in Nonsmokers Reflect Exposure to PAH-Rich Coal Combustion Emissions Cancer Res., September 1, 2001; 61(18): 6679 - 6681. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
